136 results
8-K
AKRO
Akero Therapeutics Inc
12 Jun 24
Amendments to Articles of Incorporation or Bylaws
5:23pm
as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 (“Proposal 2”), (iii) to approve, by non
S-3ASR
EX-5.2
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
such examination of law as we have deemed appropriate to give the opinion set forth below. We have relied, without independent verification, on certificates
S-3ASR
EX-5.1
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
of law as we have deemed appropriate to give the opinions set forth below. We have relied, without independent verification, on certificates of public
S-3ASR
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
transactions or otherwise. Any of these activities may stabilize or maintain the market price of the securities above independent market levels. Any … , and the effectiveness of Akero Therapeutics, Inc.’s internal control over financial reporting have been audited by Deloitte & Touche LLP, an independent registered
S-3ASR
EX-23.1
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement
S-3ASR
EX-4.2
686jk0kpu jaam0k
10 May 24
Automatic shelf registration
4:57pm
S-3ASR
EX-4.3
rf79s83e9t68dmp2yvi
10 May 24
Automatic shelf registration
4:57pm
PRE 14A
jb0tt7 0fj92u9lg4k
16 Apr 24
Preliminary proxy
4:30pm
8-K
EX-1.1
b2zce51 8o665h
6 Mar 24
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-5.1
vym29iu2dq
6 Mar 24
Entry into a Material Definitive Agreement
5:25pm
424B5
cya befk9
6 Mar 24
Prospectus supplement for primary offering
5:16pm
424B5
hp4ddpinrnocj
4 Mar 24
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.2
en61w2c 8r0mpgtfpo
4 Mar 24
Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2b HARMONY Study
7:55am
S-8
EX-5.1
y1gcvfrjwurhy
29 Feb 24
Registration of securities for employees
4:42pm
S-8
EX-23.1
8bjnvmaj8c 8a
29 Feb 24
Registration of securities for employees
4:42pm
S-8
2y4kddylbde7 8e
29 Feb 24
Registration of securities for employees
4:42pm